BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16492673)

  • 1. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages.
    Wenstrup RJ; Florer JB; Davidson JM; Phillips CL; Pfeiffer BJ; Menezes DW; Chervoneva I; Birk DE
    J Biol Chem; 2006 May; 281(18):12888-95. PubMed ID: 16492673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.
    Park AC; Phillips CL; Pfeiffer FM; Roenneburg DA; Kernien JF; Adams SM; Davidson JM; Birk DE; Greenspan DS
    Am J Pathol; 2015 Jul; 185(7):2000-11. PubMed ID: 25987251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon.
    Wenstrup RJ; Smith SM; Florer JB; Zhang G; Beason DP; Seegmiller RE; Soslowsky LJ; Birk DE
    J Biol Chem; 2011 Jun; 286(23):20455-65. PubMed ID: 21467034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Two Independent
    Bauer A; Bateman JF; Lamandé SR; Hanssen E; Kirejczyk SGM; Yee M; Ramiche A; Jagannathan V; Welle M; Leeb T; Bateman FL
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31546637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen V haploinsufficiency in a murine model of classic Ehlers-Danlos syndrome is associated with deficient structural and mechanical healing in tendons.
    Johnston JM; Connizzo BK; Shetye SS; Robinson KA; Huegel J; Rodriguez AB; Sun M; Adams SM; Birk DE; Soslowsky LJ
    J Orthop Res; 2017 Dec; 35(12):2707-2715. PubMed ID: 28387435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
    Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations due to Col5a1 haploinsufficiency in a mouse model of classic Ehlers-Danlos syndrome.
    Machol K; Polak U; Weisz-Hubshman M; Song IW; Chen S; Jiang MM; Chen-Evenson Y; Weis MAE; Keene DR; Eyre DR; Lee BH
    Hum Mol Genet; 2022 Apr; 31(8):1325-1335. PubMed ID: 34740257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome.
    Wenstrup RJ; Florer JB; Cole WG; Willing MC; Birk DE
    J Cell Biochem; 2004 May; 92(1):113-24. PubMed ID: 15095409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.
    Wenstrup RJ; Florer JB; Willing MC; Giunta C; Steinmann B; Young F; Susic M; Cole WG
    Am J Hum Genet; 2000 Jun; 66(6):1766-76. PubMed ID: 10777716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered dermal fibroblast behavior in a collagen V haploinsufficient murine model of classic Ehlers-Danlos syndrome.
    DeNigris J; Yao Q; Birk EK; Birk DE
    Connect Tissue Res; 2016; 57(1):1-9. PubMed ID: 26713685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement.
    Symoens S; Malfait F; Vlummens P; Hermanns-Lê T; Syx D; De Paepe A
    PLoS One; 2011; 6(5):e20121. PubMed ID: 21611149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
    Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
    Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type.
    Malfait F; Wenstrup RJ; De Paepe A
    Genet Med; 2010 Oct; 12(10):597-605. PubMed ID: 20847697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type V collagen controls the initiation of collagen fibril assembly.
    Wenstrup RJ; Florer JB; Brunskill EW; Bell SM; Chervoneva I; Birk DE
    J Biol Chem; 2004 Dec; 279(51):53331-7. PubMed ID: 15383546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
    Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
    Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.
    Takahara K; Schwarze U; Imamura Y; Hoffman GG; Toriello H; Smith LT; Byers PH; Greenspan DS
    Am J Hum Genet; 2002 Sep; 71(3):451-65. PubMed ID: 12145749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II.
    Bouma P; Cabral WA; Cole WG; Marini JC
    J Biol Chem; 2001 Apr; 276(16):13356-64. PubMed ID: 11278977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Ehlers-Danlos syndrome with lethal arterial events caused by a mutation in COL5A1.
    Monroe GR; Harakalova M; van der Crabben SN; Majoor-Krakauer D; Bertoli-Avella AM; Moll FL; Oranen BI; Dooijes D; Vink A; Knoers NV; Maugeri A; Pals G; Nijman IJ; van Haaften G; Baas AF
    Am J Med Genet A; 2015 Jun; 167(6):1196-203. PubMed ID: 25845371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria.
    Symoens S; Syx D; Malfait F; Callewaert B; De Backer J; Vanakker O; Coucke P; De Paepe A
    Hum Mutat; 2012 Oct; 33(10):1485-93. PubMed ID: 22696272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
    Giunta C; Steinmann B
    Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.